NOW Q1 2026 Earnings Slight EPS Miss Overshadowed by Positive Stock Reaction RLAY Q1 2026 Earnings EPS Misses Consensus PreRevenue Biotech Maintains RD Focus BCAB Q4 2025 Earnings NarrowerThanExpected Loss Drives Positive Sentiment STTK Q1 2026 Earnings Narrowerthanexpected loss highlights cost discipline amid prerevenue stage FWDI Q1 2026 Earnings Strong EPS Beat Defies Expectations Nuvalent Inc NUVL Q1 2026 Earnings PreRevenue Biotech Narrows Operating Loss Stock Edges higher